Zymeworks BC Inc

Research Zymeworks BC Inc (ZYME) on Bullrun: market cap USD 1.77B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZYME
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.77B
• Financial periodFY2025
• RevenueUSD 105.97M
• Revenue growth38.9%
• Net income-USD 81.13M
• Free cash flow-USD 34.53M

Valuation Snapshot

latest market cap is USD 1.77B.

About Zymeworks BC Inc

Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies;

Frequently asked questions

What is Zymeworks BC Inc's market cap?

Zymeworks BC Inc's market capitalization is USD 1.77B.

What does Zymeworks BC Inc do?

Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform;